157 related articles for article (PubMed ID: 35353331)
1. Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller.
Takigawa A; Sakamori R; Tahata Y; Yoshioka T; Yamada R; Kodama T; Hikita H; Yakushijin T; Ohkawa K; Hiramatsu N; Mita E; Hagiwara H; Ito T; Imai Y; Tatsumi T; Takehara T
Dig Dis Sci; 2022 Dec; 67(12):5704-5711. PubMed ID: 35353331
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns.
Okuwaki Y; Nakazawa T; Shibuya A; Ono K; Hidaka H; Watanabe M; Kokubu S; Saigenji K
J Gastroenterol; 2008; 43(1):71-8. PubMed ID: 18297439
[TBL] [Abstract][Full Text] [Related]
3. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
[TBL] [Abstract][Full Text] [Related]
5. [Influencing factors for intrahepatic distant recurrence of liver cancer after radiofrequency ablation].
Luo JT; Wei X; Zhou HY; Li Q
Zhonghua Wai Ke Za Zhi; 2009 Oct; 47(20):1529-31. PubMed ID: 20092738
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
Shiina S; Tateishi R; Arano T; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Sato T; Masuzaki R; Kondo Y; Goto T; Yoshida H; Omata M; Koike K
Am J Gastroenterol; 2012 Apr; 107(4):569-77; quiz 578. PubMed ID: 22158026
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter.
Tanaka T; Takata K; Miyayama T; Shibata K; Fukuda H; Yamauchi R; Fukunaga A; Yokoyama K; Shakado S; Sakisaka S; Hirai F
Sci Rep; 2023 Sep; 13(1):16286. PubMed ID: 37770523
[TBL] [Abstract][Full Text] [Related]
9. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
[TBL] [Abstract][Full Text] [Related]
10. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.
Umeda Y; Matsuda H; Sadamori H; Matsukawa H; Yagi T; Fujiwara T
World J Surg; 2011 Jan; 35(1):170-7. PubMed ID: 20922387
[TBL] [Abstract][Full Text] [Related]
11. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
12. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
13. A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma.
He YZ; He K; Huang RQ; Liu LW; Ye SW; Qian JL; Peng P; Luo QJ; Wang ZL; Hu ZM
Sci Rep; 2021 Apr; 11(1):8275. PubMed ID: 33859298
[TBL] [Abstract][Full Text] [Related]
14. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in Egyptian patients.
Montasser MF; Shaker MK; Albreedy AM; Montasser IF; El Dorry A
J Dig Dis; 2014 Dec; 15(12):676-83. PubMed ID: 25214183
[TBL] [Abstract][Full Text] [Related]
16. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
[TBL] [Abstract][Full Text] [Related]
18. Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Kaida T; Mima K; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Baba H
Anticancer Res; 2018 Feb; 38(2):1047-1052. PubMed ID: 29374739
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for recurrence beyond Milan criteria after radiofrequency ablation in transplantable small hepatocellular carcinoma.
Chu W; Li P; Wu X; Zhang P; Zhou H; Niu B
Rev Esp Enferm Dig; 2022 Oct; 114(10):580-585. PubMed ID: 35042367
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]